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The coordinated Response of the 
Physical and Antimicrobial Peptide 
Barriers of the Skin
Andrew W. Borkowski1 and Richard L. Gallo1
Antimicrobial peptides (AMPs) are an essential and multifunctional element 
for immune defense of the skin during infection and injury. In this issue, 
Ahrens et al. characterize the response of β-defensins, a class of AMPs, fol-
lowing acute and chronic challenges to the permeability barrier of the skin. 
Their findings suggest that the antimicrobial and permeability barriers of the 
skin are closely linked.
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The multiple defensive functions of 
human skin depend on its ability to 
detect danger from a broad range of 
physical, chemical, and microbiologi-
cal challenges, and they are intercon-
nected to minimize the potential for 
damage. The skin’s defensive functions 
are often thought of as acting through 
two simultaneously acting barriers, 
the immune antimicrobial barrier 
and the physical permeability barrier. 
Following physical injury to the skin, 
a cascade of events occurs to restore 
the breached skin barrier and reestab-
lish homeostasis. In contrast, during 
infection, microbes encounter both 
the complex lipid and protein struc-
tures of the stratum corneum and an 
array of antimicrobial molecules that 
are already present or may be trig-
gered by a set of pattern recognition 
receptors. In combination, these barri-
ers typically act to facilitate the elimi-
nation of pathogens. In recent years, 
it has been shown that the pathways 
that generate and regulate the antimi-
crobial barrier of the skin are closely 
tied to pathways that modulate per-
meability barrier function (Dorschner 
et al., 2001; Schauber et al., 2007; 
Aberg et al., 2007, 2008). In this 
issue, Ahrens et al. report that both 
acute and chronic skin barrier disrup-
tion lead to increased expression of 
murine β-defensins (mBDs)-1, -3, and 
-14 and that this increase in expres-
sion is diminished when the barrier is 
artificially restored. Their data contrib-
ute to the concept that the antimicro-
bial and permeability barriers of the 
skin are closely linked.
antimicrobial nature of the skin
The integrity of the skin barrier is 
essential for it to properly serve its 
purpose as a shield from the environ-
ment. Keratinocytes are at the forefront 
of this defense because they make up 
the majority of epidermal cells and are 
in constant contact with the outside 
world. Keratinocytes are responsible 
for producing the stratum corneum, 
the terminally differentiated outer layer 
of the epidermis composed of rigid, 
anucleate corneocytes cemented by 
hydrophobic, lipid-rich lamellar bilay-
ers that impede water loss and protect 
from pathogenic organisms (reviewed 
in Candi et al., 2005). Although kera-
tinocytes serve as a physical barrier, 
they also express an array of mol-
ecules that contribute to the antimi-
crobial properties of skin (reviewed in 
Elias, 2007). A wide arsenal of weap-
ons combats possible invaders via the 
skin. Constant desquamation of the 
skin makes it difficult for organisms 
to establish permanent residence. The 
surface of the skin is an acidic envi-
ronment (pH ∼ 5.5) uninhabitable to 
many microorganisms. Additionally, it 
has been suggested that the microflora 
that normally inhabit human skin can 
contribute to barrier defenses by com-
peting for nutrients and niches that 
more pathogenic organisms require, 
by expressing antimicrobial molecules 
that kill or inhibit the growth of patho-
genic microbes (Cogen et al., 2010; 
Nakatsuji et al., 2010), and by modu-
lating the inflammatory response (Lai 
et al., 2009).
Over the past decade, it has become 
increasingly apparent that keratinocytes 
and other resident skin cells produce 
a number of antimicrobial molecules 
important for maintaining homeosta-
sis (Gallo and Huttner, 1998). Studies 
of antimicrobial peptides (AMPs) in 
many organ systems have shown them 
to engage in a wide range of activi-
ties including direct microbial killing, 
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chemotaxis, modification of inflam-
matory responses, angiogenesis, and 
wound healing (reviewed in Lai and 
Gallo, 2009). More than 1,200 AMPs 
have been identified or predicted. 
They are generally small in size (12–50 
amino acids), are positively charged, 
and have amphipathic structures. They 
contain common secondary structures 
that vary from α-helical to β-sheets, and 
their unifying characteristic is the abil-
ity to kill microbes or inhibit them from 
growing. Cathelicidins and defensins 
are two classes of AMPs that have been 
well characterized and studied in the 
skin. The cathelicidin protein hCAP18, 
as well as the human β-defensins 
(hBDs)-1, -2, and -3, are produced in 
keratinocytes and packaged in lamellar 
bodies prior to extrusion to the stratum 
corneum (Braff et al., 2005). hBD2 and 
hBD3 are induced following activation 
with bacteria or cytokines (Liu et al., 
2002; Lai et al., 2010). hCAP18 can be 
induced by vitamin D and is activated 
proteolytically to several peptide forms, 
the most commonly studied being 
LL-37, a form that is produced predom-
inantly by neutrophils. Although these 
two groups of AMPs dominate the AMP 
literature, over 20 other AMPs have 
been identified in the skin. In addition 
to their antimicrobial activity, some 
AMPs exhibit protease/enzyme activity, 
chemotactic activity, and neuropeptide 
activity (reviewed in Braff and Gallo, 
2006). Other skin resident cells such 
as sebocytes, eccrine glands, and mast 
cells also produce AMPs, whereas neu-
trophils and natural killer cells can be 
recruited to the skin, where they depos-
it additional AMPs following wounding 
or infection (Dorschner et al., 2001). 
Elucidation of the multifunctional roles 
of AMPs in skin has made the regulation 
of their expression a focus of research 
in recent years.
AMPs fulfill a wide range of func-
tions, some yet to be characterized. 
First and foremost, AMPs exert direct 
antimicrobial activity by binding of the 
cationically charged AMP to negatively 
charged phospholipid head groups 
present in many bacteria in the form 
of lipopolysaccharide, teichoic acids, 
lipoteichoic acids, and lysophospha-
t idylglycerol (reviewed in Lai and 
Gallo, 2009). This binding results in 
membrane destabilization and pro-
duces a physical disruption of the 
membrane or cell wall of the microbe, 
leading to decreased growth or death. 
AMPs also play an important role in 
modulating the host immune response 
following infection or injury. They can 
recruit leukocytes directly or stimulate 
cells to release IL-8, MCP-1, and IFN-
α, thereby indirectly recruiting other 
effector cells, including neutrophils, 
macrophages, monocytes, immature 
dendritic cells, and T cells, to sites of 
injury/infection. These functions can 
also influence wound healing: some 
AMPs have been shown to stimulate 
migration, proliferation, and tube for-
mation by endothelial cells, stimulate 
cell proliferation, and re-epithelialize 
skin (Heilborn et al., 2003).
Interdependence of the antimicrobial 
and permeability barriers
Because AMPs play such a wide 
range of roles in skin, it is not hard to 
imagine that they would also impact 
Figure 1. Homeostasis of the physical and antimicrobial barrier of the skin. Counterclockwise from 
upper left: Under resting conditions, the multiple elements of the physical permeability barrier and 
the antimicrobial defense shield combine to resist microbial invasion in the absence of inflammation. 
Following injury, a defect in barrier function triggers a response that includes induction of antimicrobial 
peptide production. The increase in antimicrobials is deficient in patients with atopic dermatitis. Under 
normal conditions, the repair process results in increased antimicrobial expression in a setting of a 
decreased barrier, thus restoring resistance to microbial invasion. Patients with rosacea and psoriasis 
have persistent elevated expression of antimicrobials that perpetuates inflammation. Upon resolution 
of the repair process, the physical and antimicrobial barriers regain a state of homeostasis. AMP, 
antimicrobial peptide.
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Clinical Implications
•  Antimicrobial peptides play a multifunctional role in the body, 
protecting from infection, modulating immune responses, and 
contributing to wound repair.
•  Control of the antimicrobial and permeability barriers of the skin occurs 
simultaneously following disruption of the skin barrier, strengthening 
the concept that they are closely linked.
•  Antimicrobial peptide expression is dysregulated in a number of 
inflammatory skin diseases including psoriasis, rosacea, and atopic 
dermatitis.
commentary
 www.jidonline.org 287
the permeability barrier. Several papers 
reporting studies of the expression of 
endogenous AMPs in keratinocytes 
have suggested that their expres-
sion coincides with the presence of 
a number of epidermal structural 
components (involucrin, loricrin, 
keratin-1 and -10, trans glutaminase-1 
and -3, specialized lipids, and other 
processing enzymes) that may become 
part of the permeability barrier. 
Importantly, studies by Aberg et al. 
(2007, 2008) have shown that murine 
cathelin-related antimicrobial peptide 
CRAMP (the murine ortholog of LL37) 
and mBD-3 (the murine ortholog of 
hBD-2) are essential for permeability 
barrier homeostasis. This work also 
demonstrates that acute and chronic 
disruption of the physical barrier leads 
to induction of CRAMP and mBD-3.
In this issue, Ahrens et al. (2011) 
further characterize the response of 
AMP expression to barrier disruption. 
They show that mBD-1, -3, and -14 
(orthologs of hBD-1, -2, and -3) are all 
upregulated following acute barrier 
disruption methods that include tape 
stripping and acetone treatment, 
as well as a metabolically induced 
chronic barrier disruption achieved 
by maintaining mice on an essential 
fatty acid deficient diet. These meth-
ods of barrier disruption all led to 
increased levels of mBD mRNA and 
protein. Artificial restoration of the 
barrier by occlusion moderately inhib-
ited the increases in mBD expression 
following acute barrier disruption 
or drastically inhibited the increases 
following chronic barrier disruption. 
The authors also show that the growth 
factor TGF-α modulated the mBD-14 
response and that TNF-α modulates 
the mBD-3 response. These studies 
highlight the importance of AMPs to 
the permeability barrier of the skin 
and provide further evidence of a 
dynamic interplay between the phys-
ical barrier and the chemical shield 
provided by AMPs against infection 
(Figure 1).
This field remains open to discovery 
and promises to continue to advance 
our understanding of many aspects 
of skin biology. AMP dysfunction has 
been implicated in a number of skin 
diseases, including psoriasis, rosacea, 
and atopic dermatitis. In psoriasis, 
AMPs, including LL37, hBD-2, and 
hBD-3, are all upregulated and are 
believed to contribute to inflammation 
and to the pathogenesis of the dis-
ease (Gilliet and Lande, 2008; Lande 
et al., 2007). In rosacea, LL37 is also 
highly upregulated and contributes 
to the progression of the disease 
(Yamasaki et al., 2007). On the other 
hand, LL37, hBD-2, and hBD-3 are all 
downregulated in atopic dermatitis, 
leaving patients susceptible to infec-
tion (Ong et al., 2002). Based on the 
current report, it is intriguing to spec-
ulate that the decrease in AMPs after 
injury could also explain increased 
levels of transepidermal water loss 
observed in both lesional and non-
lesional skin (Werner and Lindberg, 
1985). By gaining a better understand-
ing of the processes that regulate AMP 
expression and their interactions with 
the barrier properties of the epidermis, 
it may be possible to develop novel 
and more effective therapeutics for 
diseases associated with disruption of 
physical and immunological homeo-
static mechanisms in the skin.
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